On the Mechanism of Thrombolysis by Plasmin

Author:

Ambrus Clara M.1,Back Nathan1,Ambrus Julian L.1

Affiliation:

1. Roswell Park Memorial Institute and the University of Buffalo Medical and Graduate Schools Buffalo, N. Y.

Abstract

I 131 -labeled purified human fibrin clots were introduced into the circulation of dogs at various time intervals after an infusion of human plasmin. One hour later, the clots were removed and incubated in saline at 37 C. In most cases, at the time when these clots were in the circulation, there was no significant "free" plasmin activity demonstrable in the blood. Nevertheless, the clots removed from these animals exhibited in vitro lysis upon incubation. Plasmin-antiplasmin complexes were formed in vitro with no demonstrable caseinolytic activity. These complexes were as effective in dissolving fibrin clots in vivo as the same amounts of plasmin were alone. The activator (streptokinase) alone used to activate plasminogen to plasmin was significantly less effective than streptokinase-activated-plasmin, alone or in complex form with antiplasmin. These experiments were interpreted as pointing toward the ability of fibrin to compete effectively with antiplasmin for plasmin. Thus, antiplasmin may serve as a transport form or reservoir of plasmin, releasing it when fibrin clots are available, but protecting other plasma proteins from its proteolytic effect. Other phenomena apparently confirming this hypothesis have been mentioned.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference23 articles.

1. Mechanism of clot Iysis by plasmin and the role of antiplasmin;AMBRUS C. M.;Pharmacologist,1959

2. Fibrinolytic effect of plasmin-antiplasmin complex;AMBRUS C. M.;Fed. Proc.,1960

3. Fibrinolytie agents in the therapy of thrombo-embolic disorders. Proceedings of the Conference on Thrombolytie Agents;AMBRUS J. L.;N. I. II. Hematology Study Section,1960

4. Studies on the plasmin system: II. Inhibition of plasmin by serum or plasma;NORMAN P. S.;J. Exper. Med.,1958

5. AMBRUS J. L. AMBRUS C. M. BACK N. SOKAL J. E. AND COLLINS G. L.: Clinical and experimental studios on fibrinolytic enzymes. Ann. Now York Acad. Sc. 68: 97 1957.

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Studies on the Administration of Streptokinase;Acta Medica Scandinavica;2009-04-24

2. Local Urokinase in Arterial Thromboembolism;Angiology;1980-10

3. Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn;American Journal of Hematology;1979-11

4. Die Hämostase;Hämatologie;1978

5. Clinical Use of Streptokinase;Fibrinolytics and Antifibrinolytics;1978

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3